Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Germany on Target: Cloud-based Lipid Management in MI
NCT05587621Not yet recruiting
- Sponsor
- Universitätsklinikum Jena
- Start
- Apr 2024
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in ST elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) (2 arms), sponsored by Universitätsklinikum Jena. Primary endpoint: LDL-cholesterol target attainment at 6 months. Planned start Apr 2024; status: not yet recruiting.
02
Conditions
ST elevation myocardial infarction (STEMI)non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT05587621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05587621.